2018 Pan Pacific Lymphoma Conference

 

2018 Pan Pacific Lymphoma Conference
L

Lymphoma Immunotherapy: Monoclonal Antibodies and Mechanism of Action, Antibody-Drug Conjugates, Immune Checkpoint Inhibitors, Immune-related Adverse Effects, Allogeneic HTC, T-cell Immunotherapy

By 2018 Pan Pacific Lymphoma Conference FEATURING Laura Zitella
By 2018 Pan Pacific Lymphoma Conference FEATURING Laura Zitella
160 views
August 15, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip
Interprofessional Educational Day
23:18

Administrative and Economic Implications in Lymphoma Care

2018 Pan Pacific Lymphoma Conference

15:43

Immunotherapy Advances and Updates: Overview of Immunology

2018 Pan Pacific Lymphoma Conference

L. Zitella

2.2K views
15:54

Lymphoma Immunotherapy: Monoclonal Antibodies and Mechanism of Actio…

2018 Pan Pacific Lymphoma Conference

L. Zitella

160 views
22:18

Medical Cannabis

2018 Pan Pacific Lymphoma Conference

S. Kurtin

800 views
09:46

CAR T-cell Toxicities and Team Management

2018 Pan Pacific Lymphoma Conference

S. Blumel

477 views
29:01

Team Management of CAR T: Case Study With Patient Perspective

2018 Pan Pacific Lymphoma Conference

S. Blumel

30 views
09:32

Future Economic Trends in Lymphoma Care

2018 Pan Pacific Lymphoma Conference

P. Bierman

17 views
08:35

Trends in Lymphoma Care: New drugs, Precision Medicine, Value-based …

2018 Pan Pacific Lymphoma Conference

P. Bierman

110 views